Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines
Open Access
- 15 January 2021
- journal article
- research article
- Published by SAGE Publications in Journal of Veterinary Diagnostic Investigation
- Vol. 33 (2) , 261-278
Abstract
Osteosarcoma (OSA) is a highly aggressive and metastatic neoplasm of both the canine and human patient and is the leading form of osseous neoplasia in both species worldwide. To gain deeper insight into the heterogeneous and genetically chaotic nature of OSA, we applied single-cell transcriptome (scRNA-seq) analysis to 4 canine OSA cell lines. This novel application of scRNA-seq technology to the canine genome required uploading the CanFam3.1 reference genome into an analysis pipeline (10X Genomics Cell Ranger); this methodology has not been reported previously in the canine species, to our knowledge. The scRNA-seq outputs were validated by comparing them to cDNA expression from reverse-transcription PCR (RT-PCR) and Sanger sequencing bulk analysis of 4 canine OSA cell lines (COS31, DOUG, POS, and HMPOS) for 11 genes implicated in the pathogenesis of canine OSA. The scRNA-seq outputs revealed the significant heterogeneity of gene transcription expression patterns within the cell lines investigated (COS31 and DOUG). The scRNA-seq data showed 10 distinct clusters of similarly shared transcriptomic expression patterns in COS31; 12 clusters were identified in DOUG. In addition, cRNA-seq analysis provided data for integration into the Qiagen Ingenuity Pathway Analysis software for canonical pathway analysis. Of the 81 distinct pathways identified within the clusters, 33 had been implicated in the pathogenesis of OSA, of which 18 had not been reported previously in canine OSA.Keywords
Funding Information
- University of Florida
- Gonzmart Family Foundation
- Milner Comparative Oncology Laboratory
This publication has 90 references indexed in Scilit:
- Expression of Phosphoinositide-specific phospholipase C enzymes in human osteosarcoma cell linesJournal of Cell Communication and Signaling, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Prognostic factors in canine appendicular osteosarcoma – a meta-analysisBMC Veterinary Research, 2012
- Long-Term Survivals of Stage IIB Osteosarcoma: A 20-Year Experience in a Single InstitutionClinics in Orthopedic Surgery, 2011
- Sample Type Bias in the Analysis of Cancer GenomesCancer Research, 2009
- Characterization of STAT3 activation and expression in canine and human osteosarcomaBMC Cancer, 2009
- International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly personsInternational Journal of Cancer, 2009
- Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival timesMolecular Cancer, 2009
- Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progressionBMC Genomics, 2009
- Investigating CXCR4 Expression in Canine Appendicular OsteosarcomaJournal of Veterinary Internal Medicine, 2008